Original Source(s)
Related Content
H2-blocker tachyphylaxis may limit LPR therapy
Acid suppression wanes rapidly with repeated dosing, supporting intermittent use and phenotype-directed evaluation of persistent symptoms.
October 23, 2026
-
4 min
FDA clears new generic weekly menopause patch
The once-weekly patch provides a generic alternative for menopausal symptoms and osteoporosis prevention.
by Mouj Hijazi
October 21, 2026
-
2 min
CDC flags neuro symptoms after unapproved botulinum toxin
None of the 3 symptomatic patients knew the injected product lacked FDA approval.
by Teraya Smith
October 9, 2026
-
3 min
